JAZZ News and Press, Jazz Pharmaceuticals plc From 02/28/24

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance PR Newswire – Total revenues of $3.8 billion in 2023 and $1 billion in 4Q23 – – 27% year-over-year revenue increase from combine...

SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...

Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors PR Newswire Mr. Kennedy brings wealth of experience managing high growth organizations focused on creating value for shareholders DUBLIN , Feb. 27, 2024 /PRNewswire/ -- Jazz Pharmaceu...

2024-02-25 11:40:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. For the fourth quarter of 2023, Aristo...

2024-02-21 08:05:31 ET More on Jazz Pharmaceuticals Updated View On Jazz Pharmaceuticals' 2025 Goals Jazz Pharmaceuticals' Zanidatamab Promises Growth Amidst Market Undervaluation Baupost Group steps away from Atara, Veritiv; bulks up on Clarivate, Jazz Pharma ...

Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer PR Newswire Mr. Johnson Brings Over 35 Years of Financial and Operating Experience to Leadership Team DUBLIN , Feb. 21, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq:...

Jazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024 PR Newswire DUBLIN , Feb. 14, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2023 full year and fourth qu...

2024-02-14 10:57:29 ET More on SS&C Technologies, Garrett Motion, etc. SS&C Technologies Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation McIntyre Partnerships - Garrett Motion: An Update On Our Risk/Reward Framework Tower Semiconductor beats Q4 ...

2024-02-13 20:45:43 ET Summary Baupost Group's 13F portfolio value decreased from $5.21B to $4.59B this quarter. The portfolio is heavily concentrated with Liberty Global, Liberty SiriusXM, Viasat, Alphabet, and Fidelity National Information Services accounting for ~62% of the hol...

NORTHAMPTON, MA / ACCESSWIRE / February 13, 2024 / Jazz Pharmaceuticals Originally published on LinkedIn Jazz Pharmaceuticals' Chief People Officer Heidi Manna recently appeared on an episode of the Future of HR Podcas t where she discussed our innovative work model, "Jazz Remix." Hear ...